2018
Females who maltreat animals
Felthous AR, Calhoun AJ. Females who maltreat animals. Behavioral Sciences & The Law 2018, 36: 752-765. PMID: 30556604, DOI: 10.1002/bsl.2390.Peer-Reviewed Original ResearchAn evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Calhoun A, King C, Khoury R, Grossberg GT. An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease. Expert Opinion On Pharmacotherapy 2018, 19: 1711-1717. PMID: 30244611, DOI: 10.1080/14656566.2018.1519022.Peer-Reviewed Original ResearchConceptsAlzheimer's diseaseNMDA receptor antagonist memantineSafety/tolerability dataDisease-modifying treatmentsSevere Alzheimer's diseaseCommon neurodegenerative diseaseMemantine ERTolerability dataTreatment regimenMedication adherenceCombination therapyPoor adherenceCaregiver burdenSocietal burdenDose combinationWarrants further considerationDrug AdministrationCaregiver supportCholinesterase inhibitorsPatientsDonepezilLiterature searchMemantineDiseaseNeurodegenerative diseases
2017
Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer’s disease
Calhoun A, Ko J, Grossberg GT. Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer’s disease. Expert Opinion On Emerging Drugs 2017, 22: 101-105. PMID: 28253832, DOI: 10.1080/14728214.2017.1293651.Peer-Reviewed Original ResearchConceptsNMDA receptor antagonistAlzheimer's diseaseClinical trialsReceptor antagonistCurrent phase 3 trialsPhase 3 trialCurrent clinical trialsNeuronal cell deathMajor neuropsychiatric disordersSymptom pathophysiologySymptomatic treatmentAD symptomatologyClinical symptomatologyNeuritic plaquesNeurofibrillary tanglesCurrent treatmentPotential treatmentSupplementary treatmentCholinesterase inhibitorsIdalopirdineAge 65Neuropsychiatric disordersAntagonistLiterature searchDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply